JP2012521441A - ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法 - Google Patents

ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法 Download PDF

Info

Publication number
JP2012521441A
JP2012521441A JP2012502164A JP2012502164A JP2012521441A JP 2012521441 A JP2012521441 A JP 2012521441A JP 2012502164 A JP2012502164 A JP 2012502164A JP 2012502164 A JP2012502164 A JP 2012502164A JP 2012521441 A JP2012521441 A JP 2012521441A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
kda
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012502164A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012521441A5 (enExample
Inventor
エル．ヘロン−オルソン リサ
エム．カトロン ドリュー
Original Assignee
エピトピックス，リミティド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エピトピックス，リミティド ライアビリティ カンパニー filed Critical エピトピックス，リミティド ライアビリティ カンパニー
Publication of JP2012521441A publication Critical patent/JP2012521441A/ja
Publication of JP2012521441A5 publication Critical patent/JP2012521441A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/38—Antigens from snakes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2012502164A 2009-03-23 2010-03-23 ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法 Withdrawn JP2012521441A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21077209P 2009-03-23 2009-03-23
US61/210,772 2009-03-23
PCT/US2010/028326 WO2010111273A1 (en) 2009-03-23 2010-03-23 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015098351A Division JP6092933B2 (ja) 2009-03-23 2015-05-13 ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法

Publications (2)

Publication Number Publication Date
JP2012521441A true JP2012521441A (ja) 2012-09-13
JP2012521441A5 JP2012521441A5 (enExample) 2013-05-09

Family

ID=42781438

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012502164A Withdrawn JP2012521441A (ja) 2009-03-23 2010-03-23 ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法
JP2015098351A Active JP6092933B2 (ja) 2009-03-23 2015-05-13 ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015098351A Active JP6092933B2 (ja) 2009-03-23 2015-05-13 ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法

Country Status (14)

Country Link
US (2) US9932373B2 (enExample)
EP (1) EP2411046B1 (enExample)
JP (2) JP2012521441A (enExample)
KR (4) KR101770321B1 (enExample)
CN (1) CN105582524A (enExample)
AR (1) AR075933A1 (enExample)
AU (1) AU2016201992B2 (enExample)
BR (1) BRPI1011856A2 (enExample)
CA (1) CA2756313A1 (enExample)
IL (2) IL215330A (enExample)
MX (1) MX339461B (enExample)
NZ (2) NZ595231A (enExample)
WO (1) WO2010111273A1 (enExample)
ZA (1) ZA201106959B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019531100A (ja) * 2016-10-21 2019-10-31 ソクプラ、サイエンシズ、エ、ジェニ、エス．イー．シー．Ｓｏｃｐｒａ Ｓｃｉｅｎｃｅｓ Ｅｔ Ｇｅｎｉｅ Ｓ．Ｅ．Ｃ． ワクチン構築物およびブドウ球菌感染症に対するその使用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0607323B8 (pt) 2005-02-14 2021-05-25 Epitopix Llc composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
BRPI1011856A2 (pt) 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso
AU2013202253B2 (en) * 2009-04-14 2015-03-19 Novartis Ag Compositions for immunising against Staphylococcus aureus
US9724658B2 (en) * 2011-03-28 2017-08-08 Fast & Fluid Management B.V. Method of homogenizing a liquid
US8753643B1 (en) 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use
US20170023569A1 (en) * 2014-01-10 2017-01-26 University Of Rochester Diagnostic device and method for detection of staphylococcus infection
CA2991907A1 (en) * 2015-07-10 2017-01-19 Douglas T. Burkhardt Proteins and immunizing compositions containing klebsiella proteins and methods of use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005502326A (ja) * 2001-03-27 2005-01-27 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓタンパク質および核酸
JP2008532935A (ja) * 2005-02-14 2008-08-21 エピトピックス，リミティド ライアビリティ カンパニー 黄色ブドウ球菌由来のポリペプチド及び使用方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981685A (en) 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5554372A (en) 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5830479A (en) 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
CA2182976C (en) 1994-02-09 2011-07-12 Daryll A. Emery Active immunization using a siderophore receptor protein
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6403337B1 (en) 1996-01-05 2002-06-11 Human Genome Sciences, Inc. Staphylococcus aureus genes and polypeptides
WO1997043314A2 (en) 1996-05-16 1997-11-20 The Texas A & M University System Collagen binding protein compositions and methods of use
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
EP1268774A2 (en) * 2000-03-21 2003-01-02 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
WO2002053180A2 (en) 2001-01-03 2002-07-11 Willmar Poultry Company, Inc. Immunizing compositions and methods of use
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
EP2320233A1 (en) 2001-06-15 2011-05-11 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
AU2002353764A1 (en) 2001-06-17 2003-03-18 D-Squared Biotechnologies, Inc. Staphylococci surface-exposed immunogenic polypeptides
US6720160B2 (en) 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
AU2003254555A1 (en) 2002-07-26 2004-02-23 Intercell Ag S. aureus antigene
BRPI0414267A (pt) 2003-09-19 2006-11-21 Epitopix Llc polipeptìdeos de campilobacter e métodos de uso
WO2005103073A2 (en) 2004-04-27 2005-11-03 Intercell Ag Td antigens
EP1784220B1 (en) 2004-08-26 2017-12-20 The University Of Western Ontario Bacterial iron acquisition targets
CA2581746A1 (en) * 2004-10-25 2006-06-08 The University Of Western Ontario Staphylococcus aureus isd protein-based anti-infectives
US8021885B2 (en) 2006-10-11 2011-09-20 Evonik Rohmax Additives Gmbh Method for the determination of the oxidative stability of a lubricating fluid
BRPI1011856A2 (pt) 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005502326A (ja) * 2001-03-27 2005-01-27 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓタンパク質および核酸
JP2008532935A (ja) * 2005-02-14 2008-08-21 エピトピックス，リミティド ライアビリティ カンパニー 黄色ブドウ球菌由来のポリペプチド及び使用方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019531100A (ja) * 2016-10-21 2019-10-31 ソクプラ、サイエンシズ、エ、ジェニ、エス．イー．シー．Ｓｏｃｐｒａ Ｓｃｉｅｎｃｅｓ Ｅｔ Ｇｅｎｉｅ Ｓ．Ｅ．Ｃ． ワクチン構築物およびブドウ球菌感染症に対するその使用
US11324815B2 (en) 2016-10-21 2022-05-10 Socpra—Sciences et Genie, S.E.C. Vaccine constructs and uses thereof against Staphylococcus infections
JP7181208B2 (ja) 2016-10-21 2022-11-30 ソクプラ、サイエンシズ、エ、ジェニ、エス．イー．シー． ワクチン構築物およびブドウ球菌感染症に対するその使用

Also Published As

Publication number Publication date
US20180237481A1 (en) 2018-08-23
KR101684292B1 (ko) 2016-12-08
AU2010229498A1 (en) 2011-10-13
BRPI1011856A2 (pt) 2020-11-03
EP2411046A1 (en) 2012-02-01
EP2411046B1 (en) 2017-12-06
CN105582524A (zh) 2016-05-18
US9932373B2 (en) 2018-04-03
IL248523A0 (en) 2016-12-29
CN102448489A (zh) 2012-05-09
NZ595231A (en) 2014-03-28
IL215330A (en) 2016-12-29
AU2016201992B2 (en) 2018-02-15
KR20160064237A (ko) 2016-06-07
KR20160114744A (ko) 2016-10-05
EP2411046A4 (en) 2012-09-19
KR101770321B1 (ko) 2017-09-05
US20120034258A1 (en) 2012-02-09
MX339461B (es) 2016-05-27
JP2015164949A (ja) 2015-09-17
AU2016201992A1 (en) 2016-04-21
CA2756313A1 (en) 2010-09-30
KR20150093774A (ko) 2015-08-18
WO2010111273A1 (en) 2010-09-30
NZ614557A (en) 2015-03-27
KR20120005471A (ko) 2012-01-16
JP6092933B2 (ja) 2017-03-08
AR075933A1 (es) 2011-05-04
MX2011009949A (es) 2011-10-06
ZA201106959B (en) 2012-06-27
IL215330A0 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
JP6092933B2 (ja) ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法
US9981028B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
AU2010229498B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
CN102448489B (zh) 多肽和含有革兰氏阳性多肽的免疫组合物及使用方法
AU2015258239B2 (en) Polypeptides from staphylococcus aureus and methods of use
AU2012244060B2 (en) Polypeptides from staphylococcus aureus and methods of use

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130322

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130322

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140513

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140812

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140819

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141113

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150514

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150608

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20150629

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20150626